The ENHANCE Study: taVNS and Psilocybin
RecruitingNCT05866471Phase: PHASE1Started 2025-01-27
Summary
This study will examine whether combining a single dose of psilocybin with non-invasive transcutaneous auricular vagus nerve stimulation (taVNS), a potential inducer of neuroplasticity and enhanced me
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
70 Years
Locations
University of Wisconsin - MadisonMadison, Wisconsin, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05866471